Presbyopia News

CHICAGO — In this Healio Video Perspective from the AAO meeting, Jennifer M. Loh, MD, shares results from the NEAR phase 3 clinical trials, which investigated Qlosi, a low-dose pilocarpine eye drop for the treatment of presbyopia.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Dagny Zhu, MD, and AnnMarie Hipsley, DPT, PhD, discuss laser scleral microporation for presbyopia.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Robert E. Ang, MD, presents 1-year study results of Supracor LASIK for presbyopia with two ablation profiles.

Ocuphire Pharma has dosed the first participants in the VEGA-3 phase 3 clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia, according to a press release.

In previous posts, I discussed the great potential for the use of AI-enabled technology for ophthalmology practice marketing, particularly in the area of marketing content production.

As Healio’s coverage of the American Society of Cataract and Refractive Surgery meeting continues, take a look at the most popular articles and videos so far.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, AnnMarie Hipsley, DPT, PhD, and George O. Waring IV, MD, FACS, discuss the latest advances in laser scleral microporation.

BOSTON — The use of advanced presbyopia-correcting implants is a journey for the patient, according to a speaker at the American Society of Cataract and Refractive Surgery meeting.

BOSTON — Eye drops are an “exciting” technology for presbyopia in the right candidates, but ophthalmologists must educate patients on their drawbacks, according to a speaker here.